» Articles » PMID: 36313546

Genetic Variation in Placental Insufficiency: What Have We Learned over Time?

Overview
Specialty Cell Biology
Date 2022 Oct 31
PMID 36313546
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic variation shapes placental development and function, which has long been known to impact fetal growth and pregnancy outcomes such as miscarriage or maternal pre-eclampsia. Early epidemiology studies provided evidence of a strong heritable component to these conditions with both maternal and fetal-placental genetic factors contributing. Subsequently, cytogenetic studies of the placenta and the advent of prenatal diagnosis to detect chromosomal abnormalities provided direct evidence of the importance of spontaneously arising genetic variation in the placenta, such as trisomy and uniparental disomy, drawing inferences that remain relevant to this day. Candidate gene approaches highlighted the role of genetic variation in genes influencing immune interactions at the maternal-fetal interface and angiogenic factors. More recently, the emergence of molecular techniques and in particular high-throughput technologies such as Single-Nucleotide Polymorphism (SNP) arrays, has facilitated the discovery of copy number variation and study of SNP associations with conditions related to placental insufficiency. This review integrates past and more recent knowledge to provide important insights into the role of placental function on fetal and perinatal health, as well as into the mechanisms leading to genetic variation during development.

Citing Articles

TLR signaling pathway and the effects of main immune cells and epigenetics factors on the diagnosis and treatment of infertility and sterility.

Babaei K, Azimi Nezhad M, Sedigh Ziabari S, Mirzajani E, Mozdarani H, Sharami S Heliyon. 2024; 10(15):e35345.

PMID: 39165943 PMC: 11333914. DOI: 10.1016/j.heliyon.2024.e35345.


Contribution of uniparental disomy to fetal growth restriction: a whole-exome sequencing series in a prenatal setting.

Li M, Hao N, Jiang Y, Xue H, Dai Y, Wang M Sci Rep. 2024; 14(1):238.

PMID: 38168635 PMC: 10762123. DOI: 10.1038/s41598-023-50584-5.


eoPred: predicting the placental phenotype of early-onset preeclampsia using public DNA methylation data.

Fernandez-Boyano I, Inkster A, Yuan V, Robinson W Front Genet. 2023; 14:1248088.

PMID: 37736302 PMC: 10509376. DOI: 10.3389/fgene.2023.1248088.

References
1.
Schacter B, Weitkamp L, Johnson W . Parental HLA compatibility, fetal wastage and neural tube defects: evidence for a T/t-like locus in humans. Am J Hum Genet. 1984; 36(5):1082-91. PMC: 1684526. View

2.
Galaviz-Hernandez C, Sosa-Macias M, Teran E, Garcia-Ortiz J, Lazalde-Ramos B . Paternal Determinants in Preeclampsia. Front Physiol. 2019; 9:1870. PMC: 6330890. DOI: 10.3389/fphys.2018.01870. View

3.
Burton G, Jauniaux E . Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004; 11(6):342-52. DOI: 10.1016/j.jsgi.2004.03.003. View

4.
Eckmann-Scholz C, Mallek J, von Kaisenberg C, Arnold N, Jonat W, Reiner S . Chromosomal mosaicisms in prenatal diagnosis: correlation with first trimester screening and clinical outcome. J Perinat Med. 2012; 40(3):215-23. DOI: 10.1515/jpm.2011.130. View

5.
Vilches C, Parham P . KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 2002; 20:217-51. DOI: 10.1146/annurev.immunol.20.092501.134942. View